{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:22:35Z","timestamp":1781677355387,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T00:00:00Z","timestamp":1714262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T00:00:00Z","timestamp":1714262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001778","name":"Deakin University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001778","name":"Deakin University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001778","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sarcopenia may increase non-alcoholic fatty liver disease (NAFLD) risk, but prevalence likely varies with different diagnostic criteria. This study examined the prevalence of sarcopenia and its defining components in adults with and without NAFLD and whether it varied by the method of muscle mass assessment [bioelectrical impedance (BIA) versus dual-energy X-ray absorptiometry (DXA)] and adjustment (height<jats:sup>2<\/jats:sup> versus BMI). Adults (<jats:italic>n<\/jats:italic>\u2009=\u20097266) in the UK Biobank study (45\u201379\u00a0years) with and without NAFLD diagnosed by MRI, were included. Sarcopenia was defined by the 2018 European Working Group on Sarcopenia in Older People definition, with low appendicular skeletal muscle mass (ASM) assessed by BIA and DXA and adjusted for height<jats:sup>2<\/jats:sup> or BMI. Overall, 21% of participants had NAFLD and the sex-specific prevalence of low muscle strength (3.6\u20137.2%) and sarcopenia (0.1\u20131.4%) did not differ by NAFLD status. However, NAFLD was associated with 74% (males) and 370% (females) higher prevalence of low ASM when adjusted for BMI but an 82% (males) to 89% (females) lower prevalence when adjusted for height<jats:sup>2<\/jats:sup> (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). The prevalence of impaired physical function was 40% (males, <jats:italic>P<\/jats:italic>\u2009=\u20090.08) to 123% (females, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) higher in NAFLD. In middle-aged and older adults, NAFLD was not associated with a higher prevalence of low muscle strength or sarcopenia but was associated with an increased risk of impaired physical function and low muscle mass when adjusted for BMI. These findings support the use of adiposity-based adjustments when assessing low muscle mass and the assessment of physical function in NAFLD.<\/jats:p>","DOI":"10.1007\/s00223-024-01212-5","type":"journal-article","created":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T10:01:12Z","timestamp":1714298472000},"page":"592-602","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK Biobank"],"prefix":"10.1007","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2026-9931","authenticated-orcid":false,"given":"Christine L.","family":"Freer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena S.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze-Yen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin M.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,28]]},"reference":[{"issue":"14","key":"1212_CR1","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1097\/CM9.0000000000002277","volume":"135","author":"J Liu","year":"2022","unstructured":"Liu J, Tian Y, Fu X, Mu C, Yao M, Ni Y, Liu Y et al (2022) Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: systematic review and meta-analysis. Chin Med J 135(14):1682-1691","journal-title":"Chin Med J"},{"issue":"9","key":"1212_CR2","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/imj.14709","volume":"50","author":"TD Huang","year":"2019","unstructured":"Huang TD, Behary J, Zekry A (2019) Non-alcoholic fatty liver disease (NAFLD): a review of epidemiology, risk factors, diagnosis and management. Intern Med J 50(9):1038\u20131047","journal-title":"Intern Med J"},{"issue":"1","key":"1212_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12072-019-09964-1","volume":"14","author":"C Cai","year":"2020","unstructured":"Cai C, Song X, Chen Y, Chen X, Yu C (2020) Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Hepatol Int 14(1):115\u2013126","journal-title":"Hepatol Int"},{"issue":"6","key":"1212_CR4","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s12072-019-09996-7","volume":"13","author":"JA Kim","year":"2019","unstructured":"Kim JA, Choi KM (2019) Sarcopenia and fatty liver disease. Hepatol Int 13(6):674\u2013687","journal-title":"Hepatol Int"},{"issue":"7","key":"1212_CR5","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/jbmr.3713","volume":"34","author":"LJM Alferink","year":"2019","unstructured":"Alferink LJM, Trajanoska K, Erler NS, Schoufour JD, de Knegt RJ, Ikram MA, Janssen HLA et al (2019) Nonalcoholic fatty liver disease in the Rotterdam Study: about muscle mass, sarcopenia, fat mass, and fat distribution. J Bone Miner Res 34(7):1254\u20131263","journal-title":"J Bone Miner Res"},{"issue":"6","key":"1212_CR6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/hepr.13321","volume":"49","author":"Y Seko","year":"2019","unstructured":"Seko Y, Mizuno N, Okishio S, Takahashi A, Kataoka S, Okuda K, Furuta M et al (2019) Clinical and pathological features of sarcopenia-related indices in patients with non-alcoholic fatty liver disease. Hepatol Res 49(6):627\u2013636","journal-title":"Hepatol Res"},{"issue":"1","key":"1212_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jhep.2016.08.019","volume":"66","author":"BK Koo","year":"2017","unstructured":"Koo BK, Kim D, Joo SK, Kim JH, Chang MS, Kim BG, Lee KL et al (2017) Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis. J Hepatol 66(1):123\u2013131","journal-title":"J Hepatol"},{"issue":"6","key":"1212_CR8","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3961\/jpmph.21.387","volume":"54","author":"HJ Lee","year":"2021","unstructured":"Lee HJ, Chang JS, Ahn JH, Kim MY, Park K-S, Ahn Y-S, Koh SB (2021) Association between low muscle mass and non-alcoholic fatty liver disease diagnosed using ultrasonography, magnetic resonance imaging derived proton density fat fraction, and comprehensive NAFLD score in Korea. J Prev Med Public Health 54(6):412\u2013421","journal-title":"J Prev Med Public Health"},{"issue":"8","key":"1212_CR9","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.4254\/wjh.v14.i8.1643","volume":"14","author":"NS Almeida","year":"2022","unstructured":"Almeida NS, Rocha R, de Souza CA, da Cruz ACS, Ribeiro BDR, Vieira LV, Daltro C et al (2022) Prevalence of sarcopenia using different methods in patients with non-alcoholic fatty liver disease. World J Hepatol 14(8):1643\u20131651","journal-title":"World J Hepatol"},{"issue":"1","key":"1212_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruy\u00e8re O, Cederholm T, Cooper C et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Aging 48(1):16\u201331","journal-title":"Age Aging"},{"issue":"5","key":"1212_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/gerona\/glu010","volume":"69","author":"SA Studenski","year":"2014","unstructured":"Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, Ferrucci L et al (2014) The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerentol 69(5):547\u2013558","journal-title":"J Gerentol"},{"issue":"1","key":"1212_CR12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.clnu.2017.11.021","volume":"38","author":"T-C Peng","year":"2019","unstructured":"Peng T-C, Wu L-W, Chen W-L, Liaw F-Y, Chang Y-W, Kao T-W (2019) Nonalcoholic fatty liver disease and sarcopenia in a Western population (NHANES III): the importance of sarcopenia definition. Clin Nutr 38(1):422\u2013428","journal-title":"Clin Nutr"},{"issue":"1","key":"1212_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/ggi.12227","volume":"15","author":"NH Meng","year":"2015","unstructured":"Meng NH, Li CI, Liu CS, Lin CH, Lin WY, Chang CK, Li TC et al (2015) Comparison of height-and weight-adjusted sarcopenia in a Taiwanese metropolitan older population. Geriatr Gerontol Int 15(1):45\u201353","journal-title":"Geriatr Gerontol Int"},{"issue":"4","key":"1212_CR14","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.clnu.2019.04.023","volume":"39","author":"D Gan","year":"2020","unstructured":"Gan D, Wang L, Jia M, Ru Y, Ma Y, Zheng W, Zhao X et al (2020) Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease. Clin Nutr 39(4):1124\u20131130","journal-title":"Clin Nutr"},{"issue":"1","key":"1212_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12877-020-01910-3","volume":"21","author":"Y-M Wang","year":"2021","unstructured":"Wang Y-M, Zhu K-F, Zhou W-J, Zhang Q, Deng D-F, Yang Y-C, Lu W-W et al (2021) Sarcopenia is associated with the presence of nonalcoholic fatty liver disease in Zhejiang Province, China: a cross-sectional observational study. BMC Geriatr 21(1):55","journal-title":"BMC Geriatr"},{"issue":"1","key":"1212_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2020.100197","volume":"3","author":"J Linge","year":"2021","unstructured":"Linge J, Ekstedt M, Leinhard OD (2021) Adverse muscle composition is linked to poor functional performance and metabolic comorbidities in NAFLD. JHEP Rep 3(1):100197","journal-title":"JHEP Rep"},{"issue":"3","key":"1212_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, Downey P et al (2015) UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 12(3):e1001779","journal-title":"PLoS Med"},{"key":"1212_CR18","unstructured":"National Health Service: Alcohol Units\u2014NHS; 2021. https:\/\/www.nhs.uk\/live-well\/alcohol-advice\/calculating-alcohol-units\/. Accessed 11 Nov 2022"},{"issue":"1","key":"1212_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1148\/radiology.153.1.6089263","volume":"153","author":"WT Dixon","year":"1984","unstructured":"Dixon WT (1984) Simple proton spectroscopic imaging. Radiology 153(1):189\u2013194","journal-title":"Radiology"},{"issue":"2","key":"1212_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172921","volume":"12","author":"HR Wilman","year":"2017","unstructured":"Wilman HR, Kelly M, Garratt S, Matthews PM, Milanesi M, Herlihy A, Gyngell M et al (2017) Characterisation of liver fat in the UK Biobank cohort. PLoS ONE 12(2):e0172921","journal-title":"PLoS ONE"},{"issue":"5","key":"1212_CR21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/jmri.1880010504","volume":"1","author":"GH Glover","year":"1991","unstructured":"Glover GH (1991) Multipoint Dixon technique for water and fat proton and susceptibility imaging. J Magn Reson Imaging 1(5):521\u2013530","journal-title":"J Magn Reson Imaging"},{"issue":"50","key":"1212_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013636","volume":"97","author":"SB Ahn","year":"2018","unstructured":"Ahn SB, Jun DW, Kang B-K, Kim M, Chang M, Nam E (2018) Optimal cutoff value for assessing changes in intrahepatic fat amount by using the controlled attenuation parameter in a longitudinal setting. Medicine 97(50):e13636","journal-title":"Medicine"},{"issue":"1","key":"1212_CR23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/jcsm.12503","volume":"11","author":"RM Dodds","year":"2020","unstructured":"Dodds RM, Granic A, Robinson SM, Sayer AA (2020) Sarcopenia, long-term conditions, and multimorbidity: findings from UK Biobank participants. J Cachexia Sarcopenia Muscle 11(1):62\u201368","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"8","key":"1212_CR24","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","volume":"35","author":"CL Craig","year":"2003","unstructured":"Craig CL, Marshall AL, Sj\u00f6str\u00f6m M, Bauman AE, Booth ML, Ainsworth BE, Pratt M et al (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35(8):1381\u20131395","journal-title":"Med Sci Sports Exerc"},{"issue":"5","key":"1212_CR25","first-page":"360","volume":"37","author":"AJ Viera","year":"2005","unstructured":"Viera AJ, Garrett JM (2005) Understanding interobserver agreement: the kappa statistic. Fam Med 37(5):360\u2013363","journal-title":"Fam Med"},{"issue":"3","key":"1212_CR26","first-page":"87","volume":"3","author":"S Safari","year":"2015","unstructured":"Safari S, Baratloo A, Elfil M, Negida A (2015) Evidence based emergency medicine part 2: positive and negative predictive values of diagnostic tests. Emerg 3(3):87\u201388","journal-title":"Emerg"},{"issue":"10","key":"1212_CR27","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.jamda.2020.03.007","volume":"21","author":"AM Martone","year":"2020","unstructured":"Martone AM, Marzetti E, Salini S, Zazzara MB, Santoro L, Tosato M, Picca A et al (2020) Sarcopenia identified according to the EWGSOP2 definition in community-living people: prevalence and clinical features. J Am Med Dir Assoc 21(10):1470\u20131474","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"1212_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002600","volume":"8","author":"R Dietzel","year":"2022","unstructured":"Dietzel R, Wiegmann S, Borucki D, Detzer C, Zeiner KN, Schaumburg D, Buehring B et al (2022) Prevalence of sarcopenia in patients with rheumatoid arthritis using the revised EWGSOP2 and the FNIH definition. RMD Open 8(2):e002600","journal-title":"RMD Open"},{"issue":"1","key":"1212_CR29","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12877-019-1338-1","volume":"19","author":"S Sobestiansky","year":"2019","unstructured":"Sobestiansky S, Michaelsson K, Cederholm T (2019) Sarcopenia prevalence and associations with mortality and hospitalisation by various sarcopenia definitions in 85\u201389 year old community-dwelling men: a report from the ULSAM study. BMC Geriatr 19(1):318","journal-title":"BMC Geriatr"},{"issue":"3","key":"1212_CR30","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/jcm8030291","volume":"8","author":"Y Su","year":"2019","unstructured":"Su Y, Hirayama K, Han T-F, Izutsu M, Yuki M (2019) Sarcopenia prevalence and risk factors among Japanese community dwelling older adults living in a snow-covered city according to EWGSOP2. J Clin Med 8(3):291","journal-title":"J Clin Med"},{"issue":"1","key":"1212_CR31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12877-020-01700-x","volume":"20","author":"R Moreno-Gonzalez","year":"2020","unstructured":"Moreno-Gonzalez R, Corbella X, Mattace-Raso F, Tap L, Sieber C, Freiberger E, Kostka T et al (2020) Prevalence of sarcopenia in community-dwelling older adults using the updated EWGSOP2 definition according to kidney function and albuminuria. BMC Geriatr 20(1):327","journal-title":"BMC Geriatr"},{"key":"1212_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2019.110801","volume":"131","author":"J Pacifico","year":"2020","unstructured":"Pacifico J, Geerlings MA, Reijnierse EM, Phassouliotis C, Lim WK, Maier AB (2020) Prevalence of sarcopenia as a comorbid disease: a systematic review and meta-analysis. Exp Gerentol 131(3):110801","journal-title":"Exp Gerentol"},{"issue":"9","key":"1212_CR33","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/met.2018.0077","volume":"16","author":"K Lee","year":"2018","unstructured":"Lee K (2018) Relationship between handgrip strength and nonalcoholic fatty liver disease: nationwide surveys. Metab Syndr Relat Disord 16(9):497\u2013503","journal-title":"Metab Syndr Relat Disord"},{"issue":"1","key":"1212_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep33255","volume":"6","author":"G Meng","year":"2016","unstructured":"Meng G, Wu H, Fang L, Li C, Yu F, Zhang Q, Liu L et al (2016) Relationship between grip strength and newly diagnosed nonalcoholic fatty liver disease in a large-scale adult population. Sci Rep 6(1):1\u20137","journal-title":"Sci Rep"},{"issue":"10","key":"1212_CR35","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/s41430-020-0591-x","volume":"74","author":"SH Park","year":"2020","unstructured":"Park SH, Kim DJ, Plank LD (2020) Association of grip strength with non-alcoholic fatty liver disease: investigation of the roles of insulin resistance and inflammation as mediators. Eur J Clin Nutr 74(10):1401\u20131409","journal-title":"Eur J Clin Nutr"},{"issue":"6","key":"1212_CR36","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1002\/jcsm.13099","volume":"13","author":"JY Seo","year":"2022","unstructured":"Seo JY, Cho EJ, Kim MJ, Kwak M-S, Yang JI, Chung SJ, Yim JY et al (2022) The relationship between metabolic dysfunction-associated fatty liver disease and low muscle mass in an asymptomatic Korean population. J Cachexia Sarcopenia Muscle 13(6):2953\u20132960","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1212_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2021.111442","volume":"93","author":"MD Ballesteros-Pomar","year":"2022","unstructured":"Ballesteros-Pomar MD, Gonz\u00e1lez-Arn\u00e1iz E, Pintor-de-la Maza B, Barajas-Galindo D, Ariadel-Cobo D, Gonz\u00e1lez-Roza L, Cano-Rodr\u00edguez I (2022) Bioelectrical impedance analysis as an alternative to dual-energy x-ray absorptiometry in the assessment of fat mass and appendicular lean mass in patients with obesity. Nutrition 93:111442","journal-title":"Nutrition"},{"issue":"7","key":"1212_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200465","volume":"13","author":"N Achamrah","year":"2018","unstructured":"Achamrah N, Colange G, Delay J, Rimbert A, Folope V, Petit A, Grigioni S et al (2018) Comparison of body composition assessment by DXA and BIA according to the body mass index: a retrospective study on 3655 measures. PLoS ONE 13(7):e0200465","journal-title":"PLoS ONE"},{"issue":"2","key":"1212_CR39","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/jcsm.12523","volume":"11","author":"MM Lee","year":"2020","unstructured":"Lee MM, Jebb SA, Oke J, Piernas C (2020) Reference values for skeletal muscle mass and fat mass measured by bioelectrical impedance in 390 565 UK adults. J Cachexia Sarcopenia Muscle 11(2):487\u2013496","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"6","key":"1212_CR40","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3390\/nu10060738","volume":"10","author":"SY Lee","year":"2018","unstructured":"Lee SY, Ahn S, Kim YJ, Ji MJ, Kim KM, Choi SH, Jang HC et al (2018) Comparison between dual-energy X-ray absorptiometry and bioelectrical impedance analyses for accuracy in measuring whole body muscle mass and appendicular skeletal muscle mass. Nutrients 10(6):738","journal-title":"Nutrients"},{"key":"1212_CR41","first-page":"141","volume":"28","author":"BC Wingo","year":"2018","unstructured":"Wingo BC, Barry VG, Ellis AC, Gower BA (2018) Comparison of segmental body composition estimated by bioelectrical impedance analysis and dual-energy X-ray absorptiometry. Clin Nutr 28:141\u2013147","journal-title":"Clin Nutr"},{"issue":"10","key":"1212_CR42","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S2213-8587(14)70034-8","volume":"2","author":"RR Kalyani","year":"2014","unstructured":"Kalyani RR, Corriere M, Ferrucci L (2014) Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol 2(10):819\u2013829","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"1212_CR43","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s10620-016-4037-1","volume":"61","author":"S Kinner","year":"2016","unstructured":"Kinner S, Reeder SB, Yokoo T (2016) Quantitative imaging biomarkers of NAFLD. Dig Dis Sci 61(5):1337\u20131347","journal-title":"Dig Dis Sci"},{"issue":"9","key":"1212_CR44","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","volume":"186","author":"A Fry","year":"2017","unstructured":"Fry A, Littlejohns TJ, Sudlow C, Doherty N, Adamska L, Sprosen T, Collins R et al (2017) Comparison of sociodemographic and health-related characteristics of UK biobank participants with those of the general population. Am J Epidemiol 186(9):1026\u20131034","journal-title":"Am J Epidemiol"},{"issue":"4","key":"1212_CR45","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.clnu.2021.11.014","volume":"41","author":"LM Donini","year":"2022","unstructured":"Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, Bauer JM et al (2022) Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Clin Nutr 41(4):990\u20131000","journal-title":"Clin Nutr"}],"updated-by":[{"DOI":"10.1007\/s00223-024-01235-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000}}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-024-01212-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-024-01212-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-024-01212-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T07:02:05Z","timestamp":1717570925000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-024-01212-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,28]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["1212"],"URL":"https:\/\/doi.org\/10.1007\/s00223-024-01212-5","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00223-024-01235-y","asserted-by":"object"}]},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,28]]},"assertion":[{"value":"29 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00223-024-01235-y","URL":"https:\/\/doi.org\/10.1007\/s00223-024-01235-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RMD reports honoraria for educational presentations from Abbott Nutrition and Fresenius Kabi. DS reports a clinical grant from Amgen Australia and honoraria from Abbott Nutrition, Amgen Australian and Pfizer. Christine L. Freer, Elena S. George, Sze-Yen Tan, Gavin Abbott declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"The UK Biobank study was approved by the Northwest Multicentre Research Ethics Committee and performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"Informed consent was given by all participants at the time of recruitment.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}